Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 1,791.03%740.24M | -78.70%854.21M | -62.62%39.15M | 338.29%4.01B | 113.51%104.71M | -302.97%-1.68B | -228.52%-774.85M | 465.83%829.12M | 80.35%602.89M | 123.99%146.53M |
| Profit adjustment | ||||||||||
| Investment loss (gain) | -509.06%-697.52M | 88.99%-461.49M | 174.00%170.52M | -138.19%-4.19B | 68.52%-230.41M | 14.87%-1.76B | 22.46%-731.99M | -35.38%-2.07B | -8.73%-944.07M | 13.98%-1.53B |
| Impairment and provisions: | 38.68%27.62M | -76.38%33M | -30.27%19.92M | 75.97%139.69M | -21.40%28.56M | -40.75%79.38M | 217.69%36.34M | -62.89%133.98M | -126.35%-30.88M | 87.42%361.03M |
| -Other impairments and provisions | 38.68%27.62M | -76.38%33M | -30.27%19.92M | 75.97%139.69M | -21.40%28.56M | -40.75%79.38M | 217.69%36.34M | -62.89%133.98M | -126.35%-30.88M | 87.42%361.03M |
| Revaluation surplus: | 103.56%28.06M | -33.22%-1.02B | -15.79%-789.16M | -142.62%-768.42M | -292.72%-681.52M | 1,522.42%1.8B | 479.39%353.64M | -596.77%-126.76M | -310.83%-93.21M | 115.02%25.52M |
| -Other fair value changes | 103.56%28.06M | -33.22%-1.02B | -15.79%-789.16M | -142.62%-768.42M | -292.72%-681.52M | 1,522.42%1.8B | 479.39%353.64M | -596.77%-126.76M | -310.83%-93.21M | 115.02%25.52M |
| Asset sale loss (gain): | ---761K | 58.58%-2.45M | ---- | 82.22%-5.92M | ---- | -9,027.12%-33.31M | ---- | -88.14%-365K | ---- | -133.73%-194K |
| -Loss (gain) on sale of property, machinery and equipment | ---761K | 58.58%-2.45M | ---- | 82.22%-5.92M | ---- | -9,027.12%-33.31M | ---- | -88.14%-365K | ---- | -133.73%-194K |
| Depreciation and amortization: | -7.78%150.27M | -7.97%328.87M | -13.89%162.94M | -1.05%357.36M | 2.80%189.22M | 17.79%361.14M | 20.99%184.06M | -2.67%306.61M | -7.91%152.12M | 6.41%315.01M |
| -Depreciation | 54.92%28.37M | 32.45%43.61M | 8.06%18.31M | -8.50%32.93M | 2.37%16.95M | 0.77%35.99M | -7.05%16.55M | -6.94%35.71M | -15.13%17.81M | -11.40%38.37M |
| -Amortization of intangible assets | -9.78%58.4M | -29.10%132.21M | -35.39%64.73M | 5.26%186.46M | 24.70%100.18M | 15.82%177.14M | 10.54%80.34M | 1.56%152.95M | -1.63%72.68M | 25.92%150.6M |
| Financial expense | -12.66%201.02M | -3.91%446.68M | 2.87%230.16M | 8.52%464.86M | 6.20%223.74M | 10.30%428.36M | 25.65%210.68M | 66.76%388.34M | 166.86%167.67M | 109.61%232.87M |
| Exchange Loss (gain) | -30.27%25.62M | 4.72%98.97M | -81.15%36.74M | -82.79%94.51M | -37.66%194.97M | 472.32%549.14M | 676.53%312.76M | 26.58%-147.49M | -5,465.88%-54.25M | -10,138.23%-200.87M |
| Special items | ---- | ---- | ---- | -14.31%69.67M | 106.30%59.26M | 471.63%81.31M | 1,510.20%28.73M | 749.50%14.22M | --1.78M | ---2.19M |
| Operating profit before the change of operating capital | 465.79%474.55M | 62.39%274.1M | -16.39%-129.73M | 196.95%168.79M | 70.72%-111.46M | 74.02%-174.11M | -92.30%-380.63M | -3.15%-670.27M | -37.87%-197.94M | 66.83%-649.79M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16.41%-893.18M | -17,084.55%-1.69B | 28.52%-1.07B |
| Insurance liabilities Increase (decrease) | -28.12%721.72M | 309.94%1.78B | 517.17%1B | -105.67%-846.01M | -205.48%-240.69M | -156.29%-411.34M | -78.53%228.17M | -21.55%730.69M | 224,617.55%1.06B | -57.35%931.41M |
| Special items for working capital changes | ---- | -102.45%-70.75M | ---- | --2.89B | ---- | ---- | ---- | -166.70%-405.86M | -45.35%1.3B | 1,001.29%608.46M |
| Customer's deposits increase (decrese) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -87.38%635.67M | ---- | --5.04B |
| Cash from business operations | 36.82%1.2B | -10.36%1.98B | 348.29%874.35M | 477.19%2.21B | -130.98%-352.15M | 2.90%-585.45M | -131.88%-152.46M | -112.41%-602.95M | -78.59%478.28M | 499.96%4.86B |
| Special items of business | 4,112.61%947.14M | ---- | -101.37%-23.6M | ---- | 2,208.60%1.73B | ---116.46M | --74.87M | ---- | ---- | ---- |
| Net cash from operations | 151.95%2.14B | -10.36%1.98B | -38.18%850.74M | 414.60%2.21B | 1,873.69%1.38B | -16.41%-701.91M | -116.22%-77.59M | -112.41%-602.95M | -78.59%478.28M | 499.96%4.86B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 6.94%404.62M | 8.96%990.52M | 4.29%378.36M | -47.05%909.05M | -55.34%362.81M | -21.65%1.72B | -19.82%812.37M | 46.31%2.19B | 9.26%1.01B | -20.30%1.5B |
| Sale of fixed assets | -99.97%5K | -23.36%14.07M | 5,387.42%17.01M | 3,125.83%18.36M | --310K | 55.89%569K | ---- | 88.14%365K | ---- | 133.73%194K |
| Purchase of fixed assets | -30.95%-941.34M | -207.99%-896.19M | -199.83%-718.86M | 29.17%-290.98M | -19.45%-239.75M | -57.54%-410.79M | -52.92%-200.71M | -5.26%-260.76M | -18.54%-131.25M | 13.39%-247.72M |
| Sale of subsidiaries | ---- | 100.54%8.83M | --8.69M | -1,806.18%-1.64B | ---- | 2,735.94%96.08M | 2,840.25%99.88M | ---3.65M | ---3.65M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 89.26%-29.1M | 90.98%-2.92M | -108.24%-270.93M | -19.06%-32.33M | -109.56%-130.11M |
| Recovery of cash from investments | 77.64%2.49B | ---- | 296.45%1.4B | ---- | ---713.27M | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | 84.43%-673.53M | -377.86%-137.85M | -255.77%-4.32B | 98.48%-28.85M | 84.00%-1.22B | -130.77%-1.9B | ---7.6B | 75.90%-822.42M | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -290.59%-7.39B |
| Net cash from investment operations | 105.82%1.95B | 89.56%-556.3M | 253.30%948.53M | -3,470.94%-5.33B | 47.97%-618.75M | 102.66%158.04M | -5,163.04%-1.19B | 5.26%-5.94B | 100.90%23.49M | -1,635.93%-6.27B |
| Net cash before financing | 127.63%4.1B | 145.63%1.42B | 137.52%1.8B | -473.50%-3.12B | 159.79%757.51M | 91.69%-543.87M | -352.49%-1.27B | -363.19%-6.54B | 228.93%501.77M | 10.35%-1.41B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -37.56%8.32M | -18.55%80.53M | --13.32M | -20.55%98.87M | ---- | 24.44%124.44M | -23.33%46M | 4,628.99%100M | 2,757.22%60M | ---2.21M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --500.16M | --500.16M | ---- |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.87B |
| Interest paid - financing | -4.85%-239.24M | -29.35%-394.37M | -3.61%-228.18M | -9.17%-304.88M | -59.73%-220.24M | -17.32%-279.28M | -14.78%-137.88M | ---238.05M | ---120.12M | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 15.64%1.11B | ---- | 109.58%955.53M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -113.08%-995.57M | ---726.96M | 8.99%-467.24M | ---- | -10.02%-513.39M |
| Other items of the financing business | -258.59%-4.17B | -142.25%-652.25M | -21.61%-1.16B | -1.61%1.54B | -149.20%-956.48M | 17.10%1.57B | 270.55%1.94B | 2,271.44%1.34B | -236.11%-1.14B | -104.38%-61.7M |
| Net cash from financing operations | -207.53%-4.47B | -195.93%-1.09B | -15.60%-1.45B | 382.46%1.14B | -219.21%-1.26B | -89.25%236.03M | 234.48%1.05B | -69.11%2.19B | -168.46%-784.15M | 249.82%7.11B |
| Effect of rate | -51.40%209K | -98.74%491K | -99.47%430K | -75.70%38.99M | -14.99%81.33M | 255.62%160.48M | 307.56%95.68M | 73.58%-103.12M | -225.21%-46.1M | -1,297.72%-390.37M |
| Net Cash | -207.77%-373.05M | 116.70%330.71M | 169.29%346.15M | -543.29%-1.98B | -135.24%-499.57M | 92.92%-307.84M | 24.80%-212.36M | -176.40%-4.35B | -137.34%-282.38M | 1,150.24%5.69B |
| Begining period cash | 19.76%2.01B | -53.66%1.68B | -53.66%1.68B | -3.91%3.62B | -3.91%3.62B | -54.19%3.77B | -54.19%3.77B | 181.94%8.22B | 181.94%8.22B | 20.11%2.91B |
| Cash at the end | -19.19%1.63B | 19.76%2.01B | -36.77%2.02B | -53.66%1.68B | -12.30%3.2B | -3.91%3.62B | -53.76%3.65B | -54.19%3.77B | 112.78%7.89B | 181.94%8.22B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.